Obesity significantly contributes to both the onset and progression of T2DM through mechanisms such as enhanced genetic and epigenetic susceptibility, microenvironmental changes that impair insulin signaling, β-cell dysfunction, and alterations in the microbiome–gut–brain axis. The gene discussed is INS; the disease is obesity disorder.